171 related articles for article (PubMed ID: 12471537)
21. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium.
Basu KK; Pick B; Bale R; West KP; de Caestecker JS
Gut; 2002 Dec; 51(6):776-80. PubMed ID: 12427775
[TBL] [Abstract][Full Text] [Related]
23. The economic impact of the diagnosis of dysplasia in Barrett's esophagus.
Ofman JJ; Lewin K; Ramers C; Ippoliti A; Lieberman D; Weinstein W
Am J Gastroenterol; 2000 Oct; 95(10):2946-52. PubMed ID: 11051373
[TBL] [Abstract][Full Text] [Related]
24. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results.
Sampliner RE; Fennerty B; Garewal HS
Gastrointest Endosc; 1996 Nov; 44(5):532-5. PubMed ID: 8934157
[TBL] [Abstract][Full Text] [Related]
25. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
[TBL] [Abstract][Full Text] [Related]
26. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.
Malesci A; Savarino V; Zentilin P; Belicchi M; Mela GS; Lapertosa G; Bocchia P; Ronchi G; Franceschi M
Gastrointest Endosc; 1996 Dec; 44(6):700-5. PubMed ID: 8979061
[TBL] [Abstract][Full Text] [Related]
27. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.
van Sandick JW; Bartelsman JF; van Lanschot JJ; Tytgat GN; Obertop H
Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):111-7. PubMed ID: 10656220
[TBL] [Abstract][Full Text] [Related]
28. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
Katzka DA; Castell DO
Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
[TBL] [Abstract][Full Text] [Related]
29. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus.
Sharma P; Bhattacharyya A; Garewal HS; Sampliner RE
Gastrointest Endosc; 1999 Aug; 50(2):159-64. PubMed ID: 10425406
[TBL] [Abstract][Full Text] [Related]
30. Esophageal adenocarcinoma associated with Barrett's esophagus: long-term management with laser ablation.
Ertan A; Zimmerman M; Younes M
Am J Gastroenterol; 1995 Dec; 90(12):2201-3. PubMed ID: 8540516
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus.
Grade AJ; Shah IA; Medlin SM; Ramirez FC
Gastrointest Endosc; 1999 Jul; 50(1):18-22. PubMed ID: 10385716
[TBL] [Abstract][Full Text] [Related]
32. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
Lee FI; Isaacs PE
Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
[TBL] [Abstract][Full Text] [Related]
33. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
Peters FT; Ganesh S; Kuipers EJ; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Gut; 1999 Oct; 45(4):489-94. PubMed ID: 10486353
[TBL] [Abstract][Full Text] [Related]
35. Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium.
Grade A; Pulliam G; Johnson C; Garewal H; Sampliner RE; Fass R
Am J Gastroenterol; 1997 Nov; 92(11):2040-3. PubMed ID: 9362188
[TBL] [Abstract][Full Text] [Related]
36. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up.
Sharma P; Jaffe PE; Bhattacharyya A; Sampliner RE
Gastrointest Endosc; 1999 Apr; 49(4 Pt 1):442-6. PubMed ID: 10202056
[TBL] [Abstract][Full Text] [Related]
37. New treatment for Barrett's oesophagus.
Barbezat GO
Biomed Pharmacother; 2000 Aug; 54(7):362-7. PubMed ID: 10989974
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of Barrett's esophageal cancer with special reference to endoscopic treatment].
Makuuchi H
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):249-56. PubMed ID: 10379535
[TBL] [Abstract][Full Text] [Related]
39. [Acid reflux on the esophagus. What helps in acute reflux esophagitis, how to prevent a recurrence?].
Mörk H
MMW Fortschr Med; 2000 Apr; 142(17):26-9. PubMed ID: 10879017
[TBL] [Abstract][Full Text] [Related]
40. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study.
Ortiz A; Martinez de Haro LF; Parrilla P; Morales G; Molina J; Bermejo J; Liron R; Aguilar J
Br J Surg; 1996 Feb; 83(2):274-8. PubMed ID: 8689188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
